GlassScriptPhysician profile
Michael J Paolucci
NPI 1639179500
$1,035.36
in general payments reported to CMS, 2019-2025
16 companies · $21.78 in 2025
The $21.78 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $227 · 2021: $413 · 2022: $42.72 · 2023: $53.15 · 2024: $17.52 · 2025: $21.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $334.99 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.47 | 2019-2021 | |
| Abbott Laboratories | $121.97 | 2022-2025 | Freestyle Libre 3 |
| Allergan, INC. | $79.88 | 2019-2020 | |
| Pfizer INC. | $76.69 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.56 | 2019-2021 | |
| Braintree Laboratories, INC. | $48.44 | 2019-2020 | |
| Shire North American Group INC | $32.55 | 2019 | |
| Ferring Pharmaceuticals INC. | $32.05 | 2019-2020 | |
| Amgen INC. | $20.61 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.00 | 2021 | |
| Celgene Corporation | $17.03 | 2021 | |
| Lilly USA, LLC | $15.34 | 2021 | |
| Intercept Pharmaceuticals, INC. | $13.51 | 2020 | |
| Medtronic, INC. | $13.20 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Paolucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.